Emerging Treatment of Acute Coronary Syndromes with Platelet Glycoprotein IIB/IIIA Inhibitors

被引:0
|
作者
Matthew T. Roe
David J. Moliterno
机构
[1] Cleveland Clinic Foundation,
关键词
Public Health; Acute Coronary Syndrome; Platelet Glycoprotein;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:247 / 257
页数:10
相关论文
共 50 条
  • [31] Glycoprotein IIb/IIIa receptor blockers in acute coronary syndromes
    Störk, T
    Fröhlich, E
    Möckel, M
    LANCET, 2001, 358 (9297): : 1996 - 1997
  • [32] Platelet glycoprotein IIb/IIIa inhibitors in acute ischemic stroke
    Kumar, Sudhir
    Rajshekher, G.
    Prabhakar, Subhashini
    NEUROLOGY INDIA, 2008, 56 (04) : 399 - 404
  • [33] Platelet glycoprotein IIB/IIIA receptor antagonists - An asset for treatment of unstable coronary syndromes and coronary intervention
    Ronner, E
    Dykun, Y
    Van den Brand, MJBM
    Van der Wieken, LR
    Simoons, ML
    EUROPEAN HEART JOURNAL, 1998, 19 (11) : 1608 - 1616
  • [34] Evaluating the benefits of glycoprotein, IIb/IIIa inhibitors in heart failure at baseline in acute coronary syndromes
    Srichai, MB
    Jaber, WA
    Prior, DL
    Marso, SP
    Houghtaling, PL
    Menon, V
    Simoons, ML
    Harrington, RA
    Hochman, JS
    AMERICAN HEART JOURNAL, 2004, 147 (01) : 84 - 90
  • [35] A prospective analysis of complications related to the use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes
    RM Rocha
    CT Mesquita
    MCFS Kanto
    FS Lugão
    AL Cascardo
    PS Lira
    FOD Rangel
    R Esporcatte
    Critical Care, 5 (Suppl 6):
  • [36] Thrombocytopenia following treatment with platelet glycoprotein IIb/IIIa inhibitors
    Christopoulos, CG
    BLOOD, 2003, 101 (04) : 1655 - 1655
  • [38] Costs and cost effectiveness of low molecular weight heparins and platelet glycoprotein IIb/IIIa inhibitors -: In the management of acute coronary syndromes
    Bosanquet, N
    Jönsson, B
    Fox, KAA
    PHARMACOECONOMICS, 2003, 21 (16) : 1135 - 1152
  • [39] Platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes:: a meta-analysis of all major randomised clinical trials
    Boersma, E
    Harrington, RA
    Moliterno, DJ
    White, H
    Théroux, P
    Van de Werf, F
    de Torbal, A
    Armstrong, PW
    Wallentin, LC
    Wilcox, RG
    Simes, J
    Califf, RM
    Topol, EJ
    Simoons, ML
    LANCET, 2002, 359 (9302): : 189 - 198
  • [40] Is There Still a Role for Glycoprotein IIb/IIIa Antagonists in Acute Coronary Syndromes?
    Iannetta, Loredana
    Puddu, Paolo Emilio
    Cuturello, Domenico
    Saladini, Angela
    Pellicano, Mariano
    Schiariti, Michele
    CARDIOLOGY RESEARCH, 2013, 4 (01) : 1 - 7